Onyx Healthcare Inc. (TPEX:6569)
Taiwan · Delayed Price · Currency is TWD 144.50
-8.50 (-5.56%)
Sep 4, 2025, 1:30 PM CST
Onyx Healthcare Revenue
Onyx Healthcare had revenue of 357.47M TWD in the quarter ending June 30, 2025, with 19.42% growth. This brings the company's revenue in the last twelve months to 1.33B, down -3.46% year-over-year. In the year 2024, Onyx Healthcare had annual revenue of 1.24B, down -16.85%.
Revenue (ttm)
1.33B
Revenue Growth
-3.46%
P/S Ratio
4.23
Revenue / Employee
11.12M
Employees
120
Market Cap
5.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.24B | -251.61M | -16.85% |
| Dec 31, 2023 | 1.49B | -107.41M | -6.71% |
| Dec 31, 2022 | 1.60B | 398.51M | 33.16% |
| Dec 31, 2021 | 1.20B | -145.54M | -10.80% |
| Dec 31, 2020 | 1.35B | -135.64M | -9.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Lumosa Therapeutics | 37.25M |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Center Laboratories | 1.60B |